Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Bullboard Posts
Comment by MBAon Oct 17, 2015 9:54am
130 Views
Post# 24201044

RE:From too overpromotional to too underpromotional:

RE:From too overpromotional to too underpromotional:


Keep in mind

- costs are going up as opposed to down due to synergies and also, costs are going up to implement their marketing plan to expand organic growth.  they communicate this to the market and told the market, Q4 will see higher costs but the benefits will be reflected starting in Q!.  Maybe why they are holding back on releasing the information
- forget additional acquistions as they don't have the cash to do anymore and Michael lost his ability to raise more capital through the equity markets.  They now have to rely on debt financing.

Their best strategy is to demonstrate success through the business plan.  Market is reflecting the change in strategy from a roll up company to a growth company but only 15-20% growth (not too impressive relative to what was expected in the spring)
I expect to see some acquistions to add to the growth, but things will slow down on this front for the next 6 months at least.




 

Bullboard Posts